Bioventus Files 2024 Annual Report
Ticker: BVS · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1665988
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Bioventus filed its 2024 10-K. Full financials out now.
AI Summary
Bioventus Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 11, 2025. The company, headquartered in Durham, NC, operates in the surgical and medical instruments sector. This filing provides a comprehensive overview of its financial performance and business operations for the past fiscal year.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed look at Bioventus Inc.'s financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — This is a standard annual report filing and does not inherently contain new risk-increasing information.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 20250311 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Bioventus Inc. (company) — Filer of the 10-K
- 2024 (date) — Fiscal year end
- March 11, 2025 (date) — Filing date
- Durham, NC (location) — Company headquarters
FAQ
What is the primary business of Bioventus Inc.?
Bioventus Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.
When did Bioventus Inc. file its 2024 annual report?
Bioventus Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 11, 2025.
Where is Bioventus Inc. headquartered?
Bioventus Inc. is headquartered at 4721 Emperor Boulevard, Suite 100, Durham, NC 27703.
What is the SEC file number for Bioventus Inc.'s 10-K filings?
The SEC file number for Bioventus Inc. is 001-37844.
What is the Central Index Key (CIK) for Bioventus Inc.?
The Central Index Key for Bioventus Inc. is 0001665988.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding Bioventus Inc. (BVS).